Clinical Trial Results
Clinical Trial
Results
Research Sponsor: AstraZeneca AB
Drug Studied: Benralizumab
National Clinical Trial #: NCT02814643
EudraCT #: 2016-001717-24
Protocol #: D3250C00033
Study Date: July 2016 to January 2017
Short Study Title: A study to see if benralizumab affects how the immune system reacts
to a flu vaccine and if benralizumab is safe to use
Thank you!
As a clinical study participant, you belong to a large community of participants
around the world. You help researchers answer important health questions and
discover new medical treatments.
Thank you for taking part in the clinical study for the drug called benralizumab. This
drug is being developed to treat asthma. You and all of the other participants helped
researchers learn if benralizumab affects how the lungs and the immune system react
to a flu vaccine, and if benralizumab is safe to use.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks it
is important for you to know the results of the study. An independent non-profit
organization called CISCRP prepared this summary of the study results for you with
the help of a medical writing organization. We hope it helps you understand and feel
proud of your important role in medical research. If you have questions about the
results, please speak with the study doctors or staff at your study site.
1